Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Stringhini

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
The Lancet. Infectious Diseases|February 4, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peakSilvia Stringhini, María-Eugenia Zaballa, Javier Perez-Saez, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 29, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021Silvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.
European Journal of Epidemiology|May 20, 2022
Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smokingDusan Petrovic, Barbara Bodinier, Sonia Dagnino, et al.
Lancet (London, England)|June 15, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studySilvia Stringhini, Ania Wisniak, Giovanni Piumatti, et al.
Frontiers in Public Health|June 2, 2020
Special Report: The Biology of Inequalities in Health: The Lifepath ConsortiumPaolo Vineis, Mauricio Avendano-Pabon, Henrique Barros, et al.
The Lancet Regional Health. Europe|December 7, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based studyMaría-Eugenia Zaballa, Javier Perez-Saez, Carlos de Mestral, et al.
International Journal of Public Health|July 18, 2024
Socioeconomic Status and Adherence to Preventive Measures During the COVID-19 Pandemic in Switzerland: A Population Based Digital Cohort AnalysisStefano Tancredi, Bernadette W A van der Linden, Arnaud Chiolero, et al.
Scientific Reports|November 28, 2017
Social adversity and epigenetic aging: a multi-cohort study on socioeconomic differences in peripheral blood DNA methylationGiovanni Fiorito, Silvia Polidoro, Pierre-Antoine Dugué, et al.
Lancet (London, England)|February 5, 2017
Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and womenSilvia Stringhini, Cristian Carmeli, Markus Jokela, et al.
International Journal of Public Health|October 24, 2020
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in SwitzerlandErin A West, Daniela Anker, Rebecca Amati, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
The Lancet. Infectious Diseases|February 4, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peakSilvia Stringhini, María-Eugenia Zaballa, Javier Perez-Saez, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 29, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021Silvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.
European Journal of Epidemiology|May 20, 2022
Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smokingDusan Petrovic, Barbara Bodinier, Sonia Dagnino, et al.
Lancet (London, England)|June 15, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studySilvia Stringhini, Ania Wisniak, Giovanni Piumatti, et al.
Frontiers in Public Health|June 2, 2020
Special Report: The Biology of Inequalities in Health: The Lifepath ConsortiumPaolo Vineis, Mauricio Avendano-Pabon, Henrique Barros, et al.
The Lancet Regional Health. Europe|December 7, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based studyMaría-Eugenia Zaballa, Javier Perez-Saez, Carlos de Mestral, et al.
International Journal of Public Health|July 18, 2024
Socioeconomic Status and Adherence to Preventive Measures During the COVID-19 Pandemic in Switzerland: A Population Based Digital Cohort AnalysisStefano Tancredi, Bernadette W A van der Linden, Arnaud Chiolero, et al.
Scientific Reports|November 28, 2017
Social adversity and epigenetic aging: a multi-cohort study on socioeconomic differences in peripheral blood DNA methylationGiovanni Fiorito, Silvia Polidoro, Pierre-Antoine Dugué, et al.
Lancet (London, England)|February 5, 2017
Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and womenSilvia Stringhini, Cristian Carmeli, Markus Jokela, et al.
International Journal of Public Health|October 24, 2020
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in SwitzerlandErin A West, Daniela Anker, Rebecca Amati, et al.
Pageof 22